Evicenter
MarkdownMedical informationP&T meetings
Darovasertib (IDE196)

First-line metastatic uveal melanoma, in combination with crizotinib

Also known as LXS196
Manufacturer
IDEAYA Biosciences
Launch
Not announced
Last updated
206 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of metastatic uveal melanoma

Economic impact of diagnostic testing

8 evidence topics · 9 sources

Medicare coverage of gene expression profiling of the primary tumor